MindWalk Holdings Corp. (HYFT) vs Verrica Pharmaceuticals Inc. (VRCA)

MindWalk Holdings Corp. and Verrica Pharmaceuticals Inc. are both Biotechnology companies. MindWalk Holdings Corp. and Verrica Pharmaceuticals Inc. are of similar size ($66.0M and $64.9M). Verrica Pharmaceuticals Inc. grew revenue faster over the last twelve months: 106.2% against −27.0%. Verrica Pharmaceuticals Inc. has the higher net margin (−102.8% vs −105.1%) and the higher return on invested capital (0.00% vs −464.6%). Across the 17 metrics below, Verrica Pharmaceuticals Inc. leads on 11 and MindWalk Holdings Corp. on 6.

Valuation

Metric HYFT VRCA Biotechnology median
P/E n/m n/m 8.50
P/S 5.23 2.49 9.71
P/B 12.39 17.51 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 5.14 2.56 9.21
Earnings yield (19.85%) (47.18%) (33.15%)
Free cash flow yield (14.68%) (18.02%) (25.50%)

Profitability

Metric HYFT VRCA Biotechnology median
Gross margin 60.81% 85.89% 65.16%
Operating margin (103.99%) (93.59%) 0.00%
Net margin (105.06%) (102.84%) 0.00%
Free cash flow margin (76.79%) (44.02%) 0.00%
Return on equity (122.85%) 473.29% (56.36%)
Return on assets (58.55%) (83.02%) (48.04%)
Return on invested capital (464.59%) 0.00% 0.00%

Growth

Metric HYFT VRCA Biotechnology median
Revenue growth (TTM) (26.99%) 106.21% 6.02%
EPS growth (last fiscal year) 66.15% 88.65% 30.26%
Revenue growth, 5-year CAGR (3.83%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HYFT VRCA Biotechnology median
Debt to equity 0.43 0.18 0.00
Current ratio 1.84 1.45 4.72
Net debt to EBITDA 0.62 2.59 0.96

Dividend

Metric HYFT VRCA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric HYFT VRCA Biotechnology median
Market cap 65.95m 64.93m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack